Biogen's (BIIB) Big Moves Signal Future Sale

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ
6. MSFT
7. SPY
8. SKYD
9. RCKT
10. IBM

Go back to Biogen's (BIIB) Big Moves Signal Future Sale

Biogen Reports Second Quarter 2016 Revenues of $2.9 Billion

July 21, 2016 7:00 AM EDT

Second quarter 2016 GAAP diluted EPS rise 22%; Non-GAAP diluted EPS rise 23%

Company raises financial guidance for the year and authorizes $5 billion share repurchase program

George A. Scangos, Ph.D., to step down as CEO

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) today reported second quarter 2016 financial results, including:

Total revenues of $2.9 billion, a 12% increase versus the same period in the prior year. Growth was driven by increases in worldwide revenues from the Companys multiple sclerosis (MS) and hemophilia... More